ESTROGEN REPLACEMENT THERAPY BY TRANSDERMAL ESTRADIOL ADMINISTRATION

被引：113
|
作者：
LAUFER, LR
DEFAZIO, JL
LU, JKH
MELDRUM, DR
EGGENA, P
SAMBHI, MP
HERSHMAN, JM
JUDD, HL
机构：
[1] UNIV CALIF LOS ANGELES,SCH MED,DEPT OBSTET & GYNECOL,DIV REPROD ENDOCRINOL,LOS ANGELES,CA 90024
[2] WADSWORTH VET ADM HOSP,MED SERV,LOS ANGELES,CA 90073
[3] VET ADM HOSP,MED SERV,SEPULVEDA,CA 91343
来源：
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY | 1983年 / 146卷 / 05期
关键词：
D O I：
10.1016/0002-9378(83)90796-2
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：533 / 540
页数：8
相关论文
共 50 条
  • [21] TRANSDERMAL ESTRADIOL AND MEDROXYPROGESTERONE ACETATE IN HORMONE REPLACEMENT THERAPY ARE BOTH ANTIOXIDANTS
    TRANQUILLI, AL
    MAZZANTI, L
    CUGINI, AM
    CESTER, N
    GARZETTI, GG
    ROMANINI, C
    GYNECOLOGICAL ENDOCRINOLOGY, 1995, 9 (02) : 137 - 141
  • [22] REGRESSION OF HEPATIC-TUMORS DURING TRANSDERMAL ESTRADIOL REPLACEMENT THERAPY
    GDANSKY, E
    BELLER, U
    NEUMAN, M
    HALEVY, J
    LEBENSART, PD
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1995, 74 (01) : 75 - 78
  • [23] Does Route of Administration for Estrogen Hormone Therapy Impact Risk of Venous Thromboembolism: Estradiol Transdermal System vs. Oral Estrogen-Only Hormone Therapy
    Laliberte, Francois
    Dea, Katherine
    Duh, Mei Sheng
    Kahler, Kristijan H.
    Rolli, Melanie
    Lefebvre, Patrick
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S181 - S182
  • [24] Does Route of Administration for Estrogen Hormone Therapy Impact Risk of Venous Thromboembolism: Estradiol Transdermal System vs. Oral Estrogen-Only Hormone Therapy
    Laliberte, Francois
    Dea, Katherine
    Duh, Mei Sheng
    Kahler, Kristijan H.
    Rolli, Melanie
    Lefebvre, Patrick
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2010, 17 (06): : 1224 - 1224
  • [25] CURRENT STATUS AND FUTURE-PROSPECTS OF TRANSDERMAL ESTROGEN REPLACEMENT THERAPY
    MILLERBASS, K
    ADASHI, EY
    FERTILITY AND STERILITY, 1990, 53 (06) : 961 - 974
  • [26] Histomorphometry of the postmenopausal endometrium after oral and transdermal estrogen replacement therapy
    Baracat, EC
    Simoes, MDJ
    Haidar, MA
    Neto, JE
    Novo, NF
    DeLima, GR
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 1996, 3 (01): : 44 - 50
  • [27] Transdermal estrogen replacement therapy decreases sympathetic activity in postmenopausal women
    Vongpatanasin, W
    Tuncel, M
    Mansour, Y
    Arbique, D
    Victor, RG
    CIRCULATION, 2001, 103 (24) : 2903 - 2908
  • [28] ACCEPTABILITY AND SKIN REACTIONS TO TRANSDERMAL ESTROGEN REPLACEMENT THERAPY IN RELATION TO CLIMATE
    FRENKEL, Y
    KOPERNIK, G
    LAZER, S
    TUGENDREICH, D
    ZMIRA, N
    OETTINGER, M
    TENDLER, R
    SERR, DM
    MATURITAS, 1994, 20 (01) : 31 - 36
  • [29] ESTRADERM TTS AND THE MENOPAUSE - A NEW APPROACH TO TRANSDERMAL ESTROGEN REPLACEMENT THERAPY
    JANAUD, A
    PEYRON, R
    CONTRACEPTION FERTILITE SEXUALITE, 1988, 16 (03): : 221 - 223
  • [30] Transdermal estrogen replacement therapy and plasma lipids in 693 French women
    Bongard, V
    Ferrières, J
    Ruidavets, JB
    Amouyel, P
    Arveiler, D
    Bingham, A
    Ducimetière, P
    MATURITAS, 1998, 30 (03) : 265 - 272
12345